The FDA just dropped new draft guidelines that could make it tougher for cancer drugs to get the green light. They want companies to prove their meds actually help people live longer, not just shrink tumors. While accelerated approvals aren’t off the table, the bar is definitely higher now. This means fewer, but hopefully better, cancer drugs on the market. What do you think—should survival always be the gold standard? #Health #BodyHealth #FDA